South African scientists are downplaying the danger of a new Covid-19 variant identified in the country towards the end of 2020.
South Africa on Sunday said it would suspend its rollout of the Oxford-AstraZeneca vaccine after initial trials showed "disappointing" results against the B.1.351 variant of COVID-19.
The rapid development of several COVID-19 vaccines has provided the world with some hope in the ongoing battle against the deadly virus.
South Africa is suffering a sharp spike in cases, driven by a new variant that may reduce the effectiveness of vaccines.
With a COVID-19 vaccine coming onto the market, the need to revise South Africa’s outdated patent laws has never been greater.
A deal announced at the UN will supply a new HIV drug to millions of patients in developing countries for $75 dollars, as opposed to $75 a day, which is the pill's price in the US.